Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1994-12-27
|
pubmed:abstractText |
Individuals with elevated levels of plasminogen activator inhibitor type 1 are at risk of developing atherosclerosis. The mechanisms leading to increased plasma PAI-1 concentrations are not well understood. The link observed between increased PAI-1 levels and insulin resistance has lead workers to investigate the effects of insulin or triglyceride rich lipoproteins on PAI-1 production by cultured hepatocytes or endothelial cells. However, little is known about the contribution of these cells to PAI-1 production in vivo. We have studied the expression of PAI-1 in human liver sections as well as in vessel walls from different territories, by immunocytochemistry and in situ hybridization. We have observed that normal liver endothelial cells expressed PAI-1 while parenchymal cells did not. However, this fact does not refute the role of parenchymal liver cells in pathological states. In healthy vessels, PAI-1 mRNA and protein were detected primarily at the endothelium from the lumen as well as from the vasa vasorum. In normal arteries, smooth muscle cells were able to produce PAI-1 depending on the territory tested. In deeply altered vessels, PAI-1 expression was observed in neovessels scattering the lesions, in some intimal cells and in smooth muscle cells. Local increase PAI-1 mRNA described in atherosclerotic lesions could be due to the abundant neovascularization present in the lesion as well as a raised expression in smooth muscle cells. The increased PAI-1 in atherosclerosis could lead to fibrin deposit during plaque rupture contributing further to the development and progression of the lesion.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0340-6245
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
72
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
44-53
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7974374-Arteriosclerosis,
pubmed-meshheading:7974374-Endothelium, Vascular,
pubmed-meshheading:7974374-Humans,
pubmed-meshheading:7974374-Immunohistochemistry,
pubmed-meshheading:7974374-In Situ Hybridization,
pubmed-meshheading:7974374-Liver,
pubmed-meshheading:7974374-Microtomy,
pubmed-meshheading:7974374-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:7974374-Reference Values
|
pubmed:year |
1994
|
pubmed:articleTitle |
Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls.
|
pubmed:affiliation |
Laboratory of Hematology, CHU Timone, Marseille, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|